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Summary
Background.— Left ventricular systolic function is a useful indicator of in-hospital prognosis
in patients with acute myocardial infarction. For long-term risk stratiﬁcation, however, the
variable degree of recovery that may occur during the ensuing period has also to be taken into
account.
Aims.— To analyse the prevalence, time course, determinants and correlates of late left
ventricular function recovery after myocardial infarction, from hospital discharge to 1-year
follow-up, using systematic serial assessment of left ventricular function.
Methods.— Data from 512 patients with a ﬁrst anterior myocardial infarction included in two
prospective studies on left ventricular remodelling (REVE and REVE-2) were analysed. Serial
Abbreviations: CK, creatine kinase; EF, ejection fraction; LV, left ventricular; MI, myocardial infarction; PCI, percutaneous coronary
ntervention; WMSI, Wall Motion Score Index.
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echocardiographic studies were performed before discharge, at 3months and at 1 year after
myocardial infarction. Left ventricular volumes, ejection fraction, and Wall Motion Score Index
were determined at a core echocardiographic laboratory.
Results.— In both cohorts, there was a signiﬁcant decrease in Wall Motion Score Index between
discharge and 1 year (from 1.87± 0.15 to 1.71± 0.21 [P < 0.0001] in REVE; and from 1.91± 0.15
to 1.64± 0.28 [P < 0.0001] in REVE-2), indicating an improvement in systolic function. Left ven-
tricular ejection fraction increased from 49.6± 9.5% at baseline to 51.5± 9.5% at 1 year in
REVE (P < 0.008), and from 49.8± 8.3% to 55.5± 9.8% in REVE-2 (P < 0.0001). Most of the recov-
ery occurred within the ﬁrst 3months after discharge, but there was still signiﬁcant recovery
between 3months and 1 year. Peak creatine kinase was the sole variable independently associ-
ated with left ventricular function recovery in both studies. Patients with no or minimal function
recovery had the greater increase in left ventricular volumes at 1 year.
Conclusions.— Late recovery in left ventricular function is common after discharge in patients
with acute myocardial infarction. Further research is needed to identify new parameters that
may help to predict this favourable outcome.
© 2010 Elsevier Masson SAS. All rights reserved.
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Résumé
Introduction.— L’existence d’une dysfonction systolique ventriculaire gauche est un paramètre
pronostique important en cas d’infarctus du myocarde. Cependant, le pronostic à long terme
va aussi dépendre de l’importance de la récupération qui peut survenir secondairement.
Objectifs.— Analyser chez des patients ayant un suivi échocardiographique systématique après
infarctus, la prévalence, le délai, les facteurs prédictifs et les conséquences de la récupération
tardive de fonction systolique entre la sortie de l’hôpital et la ﬁn de la première année.
Méthodes.— Nous avons utilisé les données de 512 patients avec un premier infarctus antérieur
inclus dans deux études prospectives sur le remodelage ventriculaire gauche (REVE et REVE-
2). Une échocardiographie a été réalisée avant la sortie, après trois mois et après un an. Les
volumes ventriculaires, la fraction d’éjection et le Wall Motion Score Index ont été obtenus par
lecture centralisée des échocardiographies.
Résultats.— Une amélioration de la fonction systolique pendant l’année suivant la sortie
(diminution du Wall Motion Score Index) a été mise en évidence dans les deux études (de
1,87± 0,15 à 1,71± 0,21 [p < 0,0001] dans REVE et de 1,91± 0,15 à 1,64± 0,28 [p < 0,0001] dans
REVE-2). La fraction d’éjection ventriculaire gauche a augmenté de 49,6± 9,5 % à 51,5± 9,5 %
dans REVE (p = 0,008) et de 49,8± 8,3 % à 55,5± 9,8 % dans REVE-2 (p < 0,0001). L’essentiel de
la récupération est survenu lors des trois premiers mois après la sortie mais une améliora-
tion signiﬁcative a encore été notée entre trois mois et un an. La seule variable associée de
manière indépendante à la récupération de fonction dans les deux études a été la valeur maxi-
male de créatine kinase. Les patients avec récupération de fonction minime ou absente ont eu
l’augmentation la plus importante des volumes ventriculaires gauches à un an.
Conclusions.— La récupération tardive de fonction systolique est fréquente après la sortie de
patients hospitalisés pour infarctus du myocarde. Il est nécessaire de mieux déﬁnir les variables
e évolution favorable.
Tous droits réservés.
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Introduction
The treatment of patients with acute MI has improved con-
siderably over the past decades. The widespread use of
acute reperfusion strategies and improvements in medical
therapies have been associated with signiﬁcant decrease
in event rates [1—3]. However, an important proportion
of the patients sustaining MI still presents with signiﬁcant
decrease in LV systolic function [4]. Early identiﬁcation of
these patients is important since they may beneﬁt from
speciﬁc management such as more intense antiremodelling
therapy, pronounced follow-up or automated implanted
cardioverter-deﬁbrillator [1].
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eLV systolic function is a useful indicator of in-hospital
rognosis in patients with acute MI [5]. For long-term risk
tratiﬁcation, however, the variable degree of recovery that
ay occur during the ensuing period, and which has been
elated to recovery of LV stunning and/or the effect of med-
cal therapies, has also to be taken into account. Most recent
nvestigations in this ﬁeld have analysed changes in LV func-
ion between an early time point (i.e., within the ﬁrst 24 or
8 hours after admission) and a late time point (i.e., several
eeks or months after MI), thereby analysing globally in-
ospital and post-discharge recovery [6—10]. Although this
pproach encompasses all components of LV function recov-
ry, it does not really match with current practice where
5p
a
p
t
l
f
t
s
M
S
T
s
R
m
r
a
B
s
Q
n
w
a
p
m
L
f
s
a
t
w
E
E
a
g
a
I
i
v
a
t
a
C
e40
redischarge evaluation of LV function is readily available,
nd where the remaining clinical question is more to antici-
ate the amount of recovery that occurs after discharge. We
herefore designed the present study to analyse the preva-
ence, time course, determinants and correlates of late LV
unction recovery, from hospital discharge to 1 year after
he acute event, in two recent cohorts of patients, using a
ystematic serial assessment of LV function.
ethods
tudy population
he design, and inclusion and exclusion criteria of the REVE
tudies have been published in detail elsewhere [11,12].
EVE was designed to test the hypothesis that genetic poly-
orphism in candidate genes may be associated with LV
emodelling [13]. REVE-2 was designed to study the associ-
tion of circulating biomarkers with LV remodelling [12,14].
oth studies were multicentre and prospective. The inclu-
ion criteria were the same for the two studies: ﬁrst anterior
-wave MI with at least three LV segments that were aki-
etic at predischarge echocardiography. Inclusion periods
ere February 2002 to June 2004 for REVE (266 patients)
nd February 2006 to September 2008 for REVE-2 (246
atients). The protocols were approved by the ethics com-
v
r
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h
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Table 1 Baseline characteristics.
Number of patients
Recruitment period
Age (years)
Women
Body mass index (kg/m2)
Hypertension
Current smoker
Diabetes mellitus
Initial reperfusion therapy
Thrombolysis
Primary PCI
No reperfusion therapy
Time from symptom onset to reperfusion (hours)
Killip class≥ II
Peak creatine kinase (IU/L)
Coronary angiography during hospitalization
Multivessel coronary artery disease
PCI during hospitalization
Stent implantation
Final TIMI ﬂow in the infarct-related vessel grade 3
Time from admission to baseline echography (days)
Ejection fraction (%)
Wall motion score index
End-diastolic volume (mL/m2)
End-systolic volume (mL/m2)
Values are number (%), mean± SD or median [25th and 75th percentil
in myocardial infarction.
a P < 0.05 (REVE-2 vs REVE).
b P < 0.0001 (REVE-2 vs REVE).C. Bauters et al.
ittee of the Centre Hospitalier et Universitaire de Lille,
ille, France, and written informed consent was obtained
rom each patient. In both studies, the protocol required
erial echocardiographic studies at baseline, at 3months and
t 1 year after MI. For those patients who did not return at
he designated times, information on their clinical status
as obtained through telephone interviews.
chocardiographic studies
chocardiographic data were obtained using commercially
vailable second harmonic imaging systems. Echocardio-
rams were performed by experienced ultrasonographers
nd repeated by the same operator wherever possible.
mages were recorded on optical discs. A standard imag-
ng protocol was used based on apical 4- and 2-chamber
iews; two-dimensional echocardiograms of the LV short
xis were recorded from the left parasternal region at
hree levels: mitral valve, mid-papillary muscle level and
pex. All echocardiograms were analysed at the Lille
ore Echo Laboratory on a Philips workstation, with each
chocardiographic variable analysed by one investigator. LV
olumes and EF were calculated using a modiﬁed Simpson’s
ule. Intra- and interobserver variability in the evalua-
ion of LV end-diastolic volume and end-systolic volume
as been previously reported [11]. To evaluate regional
ystolic function, the left ventricle was divided according
REVE REVE-2
266 246
2002—2004 2006—2008
58.2± 13.8 57.0± 13.8
67 (25) 46 (19)
27.0± 4.7 27.1± 4.6
120 (45) 89 (36)a
122 (46) 116 (47)
60 (23) 51 (21)
142 (54) 87 (35)b
78 (29) 128 (52)b
46 (17) 31 (13)
4 [2—7] 3.5 [2—7]
71 (27) 79 (32)
2549 [1234—3984] 2353 [1447—4198]
263 (99) 243 (99)
101 (38) 98 (40)
235 (89) 212 (86)
232 (87) 208 (85)
220 (84) 213 (91)a
7 [5—9] 4 [3—5]b
49.2± 9.5 49.3± 8.5
1.87± 0.15 1.91± 0.15a
56.5± 14.9 52.3± 14.0a
29.0± 10.6 26.9± 10.5a
es]. PCI: percutaneous coronary intervention; TIMI: thrombolysis
n 541
Table 2 Major medications at hospital discharge and
during follow-up.
REVE REVE-2
Aspirin
Discharge 97 99
3 months 92 98a
1 year 80 95b
Clopidogrel
Discharge 93 97a
3 months 72 94b
1 year 55 92b
Beta-blocker
Discharge 94 97
3 months 91 96a
1 year 89 95a
Angiotensin-converting
enzyme inhibitor
Discharge 97 97
3 months 91 94
1 year 82 86
Angiotensin II receptor
antagonist
Discharge 1 1
3 months 4 5
1 year 11 10
Aldosterone antagonist
Discharge 13 33b
3 months 14 32b
1 year 11 32b
Diuretic
Discharge 26 24
3 months 24 23
1 year 24 28
Statins
Discharge 98 94
3 months 93 97a
1 year 93 95
Data given as percentage.
a P < 0.05 (REVE-2 vs REVE).
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to a 16-segment model as recommended by the Ameri-
can Society of Echocardiography [15]. For each segment,
wall motion was scored from 1 (normal) to 4 (dyski-
netic), and the WMSI was derived; the normal WMSI value
is 1.00. Percent LV function recovery was deﬁned as
((WMSIbaseline —WMSI1 year)× 100)/(WMSIbaseline — 1) as an indi-
cator of the amount of LV dysfunction at discharge that had
recovered at 1 year. LV remodelling was deﬁned as a greater
than 20% increase in end-diastolic volume between baseline
and the 1-year follow-up examination.
Statistical analysis
STATA 9.0 (STAT Corp. College Station, Texas) was used
for the statistical analysis. Quantitative variables are pre-
sented as the mean± standard deviation or median with
25th and 75th percentiles unless otherwise indicated. Vari-
ables with skewed distribution were log-transformed before
being used as continuous variables in statistical analyses.
Continuous variables were compared with the paired or
unpaired Student’s t-test, ANOVA, or with simple linear
regression as appropriate. Discrete variables were compared
using Chi-squared analysis. A P value < 0.05 was considered
statistically signiﬁcant. Independent predictors of percent
recovery in LV function were identiﬁed by multiple lin-
ear regression. Variables signiﬁcant on univariate analysis
were entered in the multivariable model. Colinearity was
excluded by means of a correlation matrix between candi-
date predictors.
Results
Patients
Table 1 compares the baseline characteristics of the patients
included in the two studies. The patients included in REVE-
2 were more often treated by primary PCI and less often
by thrombolysis. Baseline echocardiography was performed
earlier in REVE-2. Baseline EF was similar in both studies
while WMSI was slightly higher in REVE-2.
Table 2 shows the use of major medications at hospital
discharge and during follow-up. Overall, there was a very
high use of secondary prevention treatments. Patients in
the REVE-2 cohort more often received antiplatelet agents,
particularly during the post-hospital period; antialdosterone
antagonists were also more often prescribed in REVE-2
patients.
Left ventricular function recovery
During the 1-year follow-up period, 18 patients died in REVE
(12 cardiovascular and six non-cardiovascular) and three
patients died in REVE-2 (all cardiovascular). Echocardio-
graphic follow-up was achieved in 215 patients in the REVE
cohort and in 226 patients in the REVE-2 cohort. Recovery
in LV function from baseline to 1-year follow-up, assessed
using the WMSI, is shown in Fig. 1. In both cohorts, there
was a signiﬁcant decrease in WMSI indicating an improve-
ment in systolic function (from 1.87± 0.15 to 1.71± 0.21
[P < 0.0001] in REVE; and from 1.91± 0.15 to 1.64± 0.28
[P < 0.0001] in REVE-2). Most of the recovery occurred within
t
5
4
pb P < 0.0001 (for REVE-2 vs REVE).
he ﬁrst 3months after discharge but there was still sig-
iﬁcant recovery between 3months and 1 year. Percent LV
unction recovery was higher in REVE-2 (31± 26%) than
n REVE (18± 18%; P < 0.0001); this difference remained
tatistically signiﬁcant (P < 0.0001) when adjusted for the
resence of hypertension, ﬁnal thrombolysis in MI ﬂow
rade, timing of baseline echocardiography, baseline WMSI
nd baseline end-diastolic volume. Further analysis of LV
unction recovery was therefore performed separately in the
wo cohorts.LVEF increased from 49.6± 9.5% at baseline to
1.5± 9.5% at 1 year in REVE (P = 0.008), and from
9.8± 8.3% to 55.5± 9.8% in REVE-2 (P < 0.0001). The
roportion of patients with a LVEF less or equal to 40%
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between discharge and 1-year assessment of LV function
recovery (REVE: nine patients; REVE-2: 10 patients). Per-
cent recovery in LV function was signiﬁcantly lower inigure 1. Recovery in left ventricular function from hospital dis-
harge to 1-year follow-up. Values are means± standard error of
he mean.
ecreased from 16.5% at baseline to 12.6% at 1-year
ollow-up in REVE (P = 0.0007), and from 17.6% to 7.4% in
EVE-2 (P < 0.0001).
eterminants of left ventricular function
ecovery
he predictors of recovery in LV function are listed in Table 3.
n univariate analyses, six variables were associated with
V function recovery in both cohorts: Killip class, use of
eperfusion, peak CK, baseline WMSI, baseline end-diastolic
olume and the use of diuretics. In multivariable analy-
is, peak CK was the sole variable independently associated
p
p
1
P
Table 3 Baseline predictors of percent recovery in left ventr
Univariable
Study/variables  coefﬁcie
REVE
Killip class≥ II —0.210
Peak creatine kinase —0.209
Diuretic —0.204
WMSI —0.159
No reperfusion therapy 0.155
End-systolic volume —0.148
End-diastolic volume —0.137
REVE-2
Peak creatine kinase —0.465
WMSI —0.419
Ejection fraction 0.321
Diuretic —0.308
Aldosterone antagonists —0.274
Killip class≥ II —0.240
End-systolic volume —0.205
No reperfusion therapy 0.189
Time from symptom onset to reperfusion —0.184
Primary PCI —0.156
PCI: percutaneous coronary intervention; WMSI: Wall Motion Score IndeC. Bauters et al.
ith LV function recovery in both cohorts. Fig. 2 illustrates
he negative relationship between peak CK and LV function
ecovery.
orrelates of left ventricular function
ecovery
he relationships between LV function recovery and LV vol-
mes are shown in Fig. 3. Overall, in both cohorts there
as a progressive increase in LV end-diastolic and end-
ystolic volumes throughout the follow-up period, indicating
V remodelling. Patients with no or minimal LV function
ecovery had the greater increase in LV volumes; conversely,
atients with high recovery in LV function had no or minimal
ncrease in LV volumes. Similar results were obtained when
V remodelling was deﬁned as a qualitative variable (≥ 20%
ncrease in LV end-diastolic volume from baseline to 1-year
ollow-up): in REVE, the rates of LV remodelling were 52,
4, 27 and 19%, in the 1st, 2nd, 3rd and 4th quartiles for LV
unction recovery, respectively (P = 0.001); while in REVE-
, the proportions were 63, 45, 23 and 23%, respectively
P < 0.0001).
Nineteen patients were hospitalized for heart failureatients needing hospitalization for heart failure com-
ared to patients without such event (REVE: 6.8± 15.4% vs
8.5± 17.9%, P = 0.05; REVE-2: 5.1± 14.8% vs 32.1± 25.6%,
= 0.001).
icular function at 1 year.
analysis Multivariable analysis
nt P  coefﬁcient P
0.002 —0.158 0.033
0.003 —0.148 0.047
0.003 — —
0.022 — —
0.026 — —
0.034 — —
0.049 — —
<0.0001 —0.413 < 0.0001
< 0.0001 —0.185 0.011
< 0.0001 — —
<0.0001 — —
<0.0001 — —
<0.0001 — —
0.002 — —
0.005 — —
0.011 —0.203 0.008
0.022 — —
x.
Late recovery in systolic function after myocardial infarction
Figure 2. Recovery in left ventricular function according to peak
creatine kinase concentrations. Left ventricular function recovery
is from hospital discharge to 1-year follow-up. Peak creatine kinase
concentrations are divided into quartiles for REVE and REVE-2. Val-
ues are means± standard error of the mean.
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Figure 3. Changes in left ventricular volumes from hospital discharge t
percent left-ventricular function recovery. First quartile: open circles; s
quartile: closed squares. Values are means± standard error of the mean543
iscussion
ur study demonstrates signiﬁcant late recovery in LV
unction after inaugural anterior MI. In the most recent
ohort (REVE-2), approximately one-third of LV dysfunction
resent at discharge had recovered at 1-year follow-up.
lthough previous studies using echocardiography, con-
rast ventriculography or magnetic resonance imaging have
lready reported progressive improvements in LV function
ithin weeks or months following MI [6—10], our study pro-
ides several new insights into this process. Firstly, while
n most previous studies baseline LV function was assessed
arly (preintervention [8], less than 12 hours [9], less than
4 hours [6,7], and less than 48 hours [10]), our baseline
easurements were performed later (median of 7 days in
EVE and 4 days in REVE-2). Early (in-hospital) improve-
ent was therefore not taken into account in the present
tudy and our ﬁndings approximate the amount of recovery
hat can be expected post-discharge, providing information
hat can be more useful to clinicians in modern practice
here predischarge echocardiography is easily obtained in
I patients. In addition, our study was performed in a
arge number of patients and using contemporary treat-
ents including high rates of reperfusion, quasi-systematic
se of angiotensin-converting enzyme inhibitors and beta-
lockers, and signiﬁcant use of aldosterone antagonists, all
f which have been associated with improvements in LV func-
ion after MI [16—18].
Patients with no or minimal recovery in LV function
ere at risk of LV remodelling and rehospitalization for
eart failure while patients with high recovery had a bet-
er outcome. This ﬁnding, which conﬁrms those of previous
tudies [7,8], underscores the potential interest of mod-
ls that could be used at hospital discharge to predict LV
o 1-year follow-up. Patients were grouped according to quartiles of
econd quartile: open squares; third quartile: closed circles; fourth
. P values are for ANOVA.
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[44
unction recovery. Such information would help clinicians
elect patients who should receive treatments that depend
n the level of LV function in the chronic post-MI phase,
uch as the automated implanted cardioverter-deﬁbrillator
19]. Although we found that several variables were asso-
iated with recovery, the sole independent predictor that
as replicated in both cohorts was peak CK. Post-infarction
V dysfunction associated with a limited increase in serum
K —probably indicating viable myocardium— was the most
onsistent indicator of functional improvement in previ-
us studies [6—9]. Further research is needed to identify
nd/or validate, in large cohorts of patients, other mark-
rs, which could help reﬁne risk stratiﬁcation. These could
e imaging markers such as new echocardiographic param-
ters [10] or variables obtained by magnetic resonance
maging [9]; alternatively, speciﬁc biological markers identi-
ed using new research strategies such as proteomics could
lso emerge [14,20]. For the time being, our results sup-
ort a repeated assessment of LV function in all patients
ith LV dysfunction at discharge to assess the degree of
ecovery.
In spite of adjustments for observed differences in
aseline characteristics, the late recovery in LV systolic
unction was greater in the 2006—2008 period (REVE-
) than in the 2002—2004 period (REVE). The design of
ur study does not allow us to provide a deﬁnite expla-
ation for this ﬁnding. Baseline echocardiography was
erformed earlier in REVE-2, but the difference in recov-
ry remained highly statistically signiﬁcant when adjusted
or this variable. The higher use of PCI, antiplatelet agents,
eta-blockers, and aldosterone antagonists might play a
ole. Alternatively, other factors that were not recorded
n our databases such as better anticoagulant regimens,
igher use of glycoprotein IIb/IIIa inhibitors or improve-
ents in PCI procedure such as thromboaspiration might
lso have resulted in more viable myocardium and conse-
uently in a greater potential for recovery in LV systolic
unction.
Finally, we acknowledge that our results were obtained in
elected patients with a ﬁrst anterior MI and that any extrap-
lation to patients with another location of MI or to patients
ith recurrent MI should be made with caution. On the other
and, our very homogeneous study population allows an easy
stimation of residual LV dysfunction prior to discharge and
f its recovery subsequently.
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